219 related articles for article (PubMed ID: 8202451)
1. Effect of the strain of Toxoplasma gondii on the development of toxoplasmic encephalitis in mice treated with antibody to interferon-gamma.
Suzuki Y; Joh K
Parasitol Res; 1994; 80(2):125-30. PubMed ID: 8202451
[TBL] [Abstract][Full Text] [Related]
2. Importance of endogenous IFN-gamma for prevention of toxoplasmic encephalitis in mice.
Suzuki Y; Conley FK; Remington JS
J Immunol; 1989 Sep; 143(6):2045-50. PubMed ID: 2506275
[TBL] [Abstract][Full Text] [Related]
3. A gene(s) within the H-2D region determines the development of toxoplasmic encephalitis in mice.
Suzuki Y; Joh K; Orellana MA; Conley FK; Remington JS
Immunology; 1991 Dec; 74(4):732-9. PubMed ID: 1783431
[TBL] [Abstract][Full Text] [Related]
4. Treatment of toxoplasmic encephalitis in mice with recombinant gamma interferon.
Suzuki Y; Conley FK; Remington JS
Infect Immun; 1990 Sep; 58(9):3050-5. PubMed ID: 2387632
[TBL] [Abstract][Full Text] [Related]
5. Toxoplasma gondii: induction of toxoplasmic encephalitis in mice with chronic infection by inoculation of a murine leukemia virus inducing immunodeficiency.
Watanabe H; Suzuki Y; Makino M; Fujiwara M
Exp Parasitol; 1993 Feb; 76(1):39-45. PubMed ID: 8385626
[TBL] [Abstract][Full Text] [Related]
6. Induction of tumor necrosis factor-alpha and inducible nitric oxide synthase fails to prevent toxoplasmic encephalitis in the absence of interferon-gamma in genetically resistant BALB/c mice.
Suzuki Y; Kang H; Parmley S; Lim S; Park D
Microbes Infect; 2000 Apr; 2(5):455-62. PubMed ID: 10865190
[TBL] [Abstract][Full Text] [Related]
7. Decreased resistance of B cell-deficient mice to infection with Toxoplasma gondii despite unimpaired expression of IFN-gamma, TNF-alpha, and inducible nitric oxide synthase.
Kang H; Remington JS; Suzuki Y
J Immunol; 2000 Mar; 164(5):2629-34. PubMed ID: 10679102
[TBL] [Abstract][Full Text] [Related]
8. IL-4 is protective against development of toxoplasmic encephalitis.
Suzuki Y; Yang Q; Yang S; Nguyen N; Lim S; Liesenfeld O; Kojima T; Remington JS
J Immunol; 1996 Sep; 157(6):2564-9. PubMed ID: 8805658
[TBL] [Abstract][Full Text] [Related]
9. Definitive identification of a gene that confers resistance against Toxoplasma cyst burden and encephalitis.
Brown CR; Hunter CA; Estes RG; Beckmann E; Forman J; David C; Remington JS; McLeod R
Immunology; 1995 Jul; 85(3):419-28. PubMed ID: 7558130
[TBL] [Abstract][Full Text] [Related]
10. Susceptibility to chronic infection with Toxoplasma gondii does not correlate with susceptibility to acute infection in mice.
Suzuki Y; Orellana MA; Wong SY; Conley FK; Remington JS
Infect Immun; 1993 Jun; 61(6):2284-8. PubMed ID: 8500870
[TBL] [Abstract][Full Text] [Related]
11. A morphological study of chronic cerebral toxoplasmosis in mice: comparison of four different strains of Toxoplasma gondii.
Ferguson DJ; Huskinson-Mark J; Araujo FG; Remington JS
Parasitol Res; 1994; 80(6):493-501. PubMed ID: 7808999
[TBL] [Abstract][Full Text] [Related]
12. Involvement of apoptosis and interferon-gamma in murine toxoplasmosis.
Shen DF; Matteson DM; Tuaillon N; Suedekum BK; Buggage RR; Chan CC
Invest Ophthalmol Vis Sci; 2001 Aug; 42(9):2031-6. PubMed ID: 11481268
[TBL] [Abstract][Full Text] [Related]
13. Murine model of intracerebral toxoplasmosis.
Hofflin JM; Conley FK; Remington JS
J Infect Dis; 1987 Mar; 155(3):550-7. PubMed ID: 3805777
[TBL] [Abstract][Full Text] [Related]
14. The CD28/B7 interaction is not required for resistance to Toxoplasma gondii in the brain but contributes to the development of immunopathology.
Reichmann G; Villegas EN; Craig L; Peach R; Hunter CA
J Immunol; 1999 Sep; 163(6):3354-62. PubMed ID: 10477605
[TBL] [Abstract][Full Text] [Related]
15. Temporal differences in the expression of mRNA for IL-10 and IFN-gamma in the brains and spleens of C57BL/10 mice infected with Toxoplasma gondii.
Burke JM; Roberts CW; Hunter CA; Murray M; Alexander J
Parasite Immunol; 1994 Jun; 16(6):305-14. PubMed ID: 7970867
[TBL] [Abstract][Full Text] [Related]
16. Genetic resistance against acute toxoplasmosis depends on the strain of Toxoplasma gondii.
Suzuki Y; Yang Q; Remington JS
J Parasitol; 1995 Dec; 81(6):1032-4. PubMed ID: 8544050
[TBL] [Abstract][Full Text] [Related]
17. Impaired resistance to the development of toxoplasmic encephalitis in interleukin-6-deficient mice.
Suzuki Y; Rani S; Liesenfeld O; Kojima T; Lim S; Nguyen TA; Dalrymple SA; Murray R; Remington JS
Infect Immun; 1997 Jun; 65(6):2339-45. PubMed ID: 9169772
[TBL] [Abstract][Full Text] [Related]
18. Previous Infection with Plasmodium berghei Confers Resistance to Toxoplasma gondii Infection in Mice.
Lee DH; Chu KB; Kang HJ; Lee SH; Quan FS
Korean J Parasitol; 2019 Apr; 57(2):93-99. PubMed ID: 31104401
[TBL] [Abstract][Full Text] [Related]
19. Characteristics of Infection Immunity Regulated by
Hwang YS; Shin JH; Yang JP; Jung BK; Lee SH; Shin EH
Front Immunol; 2018; 9():158. PubMed ID: 29459868
[TBL] [Abstract][Full Text] [Related]
20. Kinetics of systemic cytokine and brain chemokine gene expression in murine toxoplasma infection.
Aviles H; Stiles J; O'Donnell P; Orshal J; Leid J; Sonnenfeld G; Monroy F
J Parasitol; 2008 Dec; 94(6):1282-8. PubMed ID: 19127964
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
